SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-010318
Filing Date
2019-08-08
Accepted
2019-08-07 17:49:15
Documents
64
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 AERI 6.30.2019 aeri10-qx63019.htm   iXBRL 10-Q 1159043
2 AERI 6.30.2019 EX 31.1 aeri6302019ex311.htm EX-31.1 16411
3 AERI 6.30.2019 EX 31.2 aeri6302019ex312.htm EX-31.2 16508
4 AERI 6.30.2019 EX 32.1 aeri6302019ex321.htm EX-32.1 10035
5 AERI 6.30.2019 EX 32.2 aeri6302019ex322.htm EX-32.2 9977
  Complete submission text file 0001628280-19-010318.txt   5368300

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20190630.xsd EX-101.SCH 37821
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20190630_cal.xml EX-101.CAL 64657
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20190630_def.xml EX-101.DEF 176981
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20190630_lab.xml EX-101.LAB 573411
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20190630_pre.xml EX-101.PRE 323754
11 EXTRACTED XBRL INSTANCE DOCUMENT aeri10-qx63019_htm.xml XML 761425
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 191006746
SIC: 2836 Biological Products, (No Diagnostic Substances)